Article
Quality of Care Takes Precedence for Breast Cancer Patients in New Jersey
Horizon BCBS partners with RCCA to improve quality of care for breast cancer patients by evaluating their molecular subtype before administering treatment.
Horizon Blue Cross Blue Shield of New Jersey announced Tuesday that it has joined with Hackensack-based Regional Cancer Care Associates, one of the nation's largest oncology groups, to create an innovative program to deliver specialized care to breast cancer patients. The RCCA physicians, more than 100 at 24 New Jersey locations, will be compensated for the quality rather than the quantity of care their breast cancer patients receive.
The program began Oct. 1 and uses a real-time data platform, developed by the Hackensack-based oncology data firm COTA, Inc., that customizes treatment by categorizing a patient’s cancer by molecular subtype. The COTA platform also supports the effort to move from a fee-for-service to value-based reimbursement system for physicians.
Link to the news on NJBIZ: http://bit.ly/1rg4vS8
